Two Sigma Investments, LP Cor Medix Inc. Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 128,555 shares of CRMD stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,555

Previous 316,963 59.44%

Holding current value

$1.46 Million

Previous $3.9 Million 60.6%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$10.07 - $14.83 $1.9 Million - $2.79 Million	-188,408 Reduced 59.44%	128,555 $1.54 Million
Q2 2025 Aug 14, 2025	BUY	$5.86 - $16.56 $1.69 Million - $4.79 Million	289,013 Added 1034.04%	316,963 $3.9 Million
Q1 2025 May 15, 2025	SELL	$6.16 - $12.57 $21,800 - $44,485	-3,539 Reduced 11.24%	27,950 $172,000
Q4 2024 Feb 14, 2025	BUY	$8.1 - $13.59 $42,030 - $70,518	5,189 Added 19.73%	31,489 $255,000
Q3 2024 Nov 14, 2024	SELL	$3.64 - $8.23 $474,787 - $1.07 Million	-130,436 Reduced 83.22%	26,300 $212,000

Q2 2024 Aug 14, 2024	BUY	$4.08 - $6.39 $382,504 - $599,068	93,751 Added 148.85%	156,736 $678,000
Q1 2024 May 15, 2024	SELL	$2.94 - $4.24 $337,373 - $486,552	-114,753 Reduced 64.56%	62,985 $267,000
Q4 2023 Feb 14, 2024	SELL	$3.0 - $4.01 $152,613 - $203,992	-50,871 Reduced 22.25%	177,738 $668,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $682,232 - $845,210	189,509 Added 484.68%	228,609 $845,000
Q2 2023 Aug 14, 2023	SELL	$3.94 - $5.8 $219,777 - $323,529	-55,781 Reduced 58.79%	39,100 $154,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $13,800 - $19,758	-4,286 Reduced 4.32%	94,881 $392,000
Q4 2022 Feb 14, 2023	SELL	$2.81 - $4.45 $50,891 - $80,593	-18,111 Reduced 15.44%	99,167 $418,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $241,628 - $644,343	-85,684 Reduced 42.22%	117,278 $332,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $357,728 - $735,111	131,036 Added 182.18%	202,962 $816,000
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $126,137 - $205,508	-32,934 Reduced 31.41%	71,926 $394,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $109,059 - $135,652	-24,398 Reduced 18.88%	104,860 $477,000
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $309,711 - $493,732	-69,442 Reduced 34.95%	129,258 $601,000
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $1.2 Million - $2 Million	198,700 New	198,700 $1.36 Million
Q1 2021 May 17, 2021	SELL	$6.84 - $17.58 $1.04 Million - $2.68 Million	-152,369 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.0 - $9.15 $391,215 - $715,923	78,243 Added 105.55%	152,369 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $78,408 - $121,770	19,800 Added 36.45%	74,126 $447,000
Q2 2020 Aug 14, 2020	BUY	$3.08 - $6.56 $167,324 - $356,378	54,326 New	54,326 $342,000

Others Institutions Holding CRMD

# of Institutions

204

Shares Held

41.2M

Call Options Held

1.33M

Put Options Held

1.3M

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $467M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Cor Medix Inc. Transaction History